QA: Immunic INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001280776_2024_Immunic_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001280776, Immunic INC

  xvar xval
0 AssetsCurrent 52,534,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 466,000
3 remainder_Assets 1,299,000
4 LiabilitiesCurrent 24,729,000
5 LiabilitiesNoncurrent 639,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,008,000
9 ResearchAndDevelopmentExpense 83,215,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 5,611,000
13 remainder_ComprehensiveNetIncome 724,000
  yvar yval
0 Assets 54,299,000
1 Liabilities 25,368,000
2 Expenses 99,223,000
3 Revenues 0
4 StockholdersEquity 28,931,000
5 NetIncome -93,612,000
6 ComprehensiveNetIncome -93,250,000
7 BaseVar 92,612,500
8 EconomicCapitalRatiobeforeLimitedLiability -0.758
9 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Change over Time